Liberty One Investment Management, LLC Krystal Biotech, Inc. Transaction History
Liberty One Investment Management, LLC
- $969 Million
- Q3 2024
A detailed history of Liberty One Investment Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Liberty One Investment Management, LLC holds 13 shares of KRYS stock, worth $2,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 140
90.71%
Holding current value
$2,090
Previous $26,000
92.31%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding KRYS
# of Institutions
310Shares Held
24.3MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$635 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$458 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$422 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$234 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$159 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.13B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...